COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,226 Articles (22,733 medRxiv, 8,493 bioRxiv)

Most recent first Previous |  Page 111: Articles 1101-1110  | Next

Optimizing SARS-CoV-2 RBD Boundaries for Enhanced E. coli Expression
Biswas, A., Sarkar, A., Raran-Kurussi, S., Mandal, K.
10.1101/2025.01.16.633331 — Posted: 2025-01-16
SARS-CoV-2 Infection and Long-Term Risk of Cardiovascular and Renal Morbidity
Boyd, H. A., Junker, T. G., Biering-Sorensen, T., Wohlfahrt, J., Hviid, A.
10.1101/2025.01.14.25320050 — Posted: 2025-01-15
Decline of Antimicrobial Resistance in Pseudomonas aeruginosa Bacteremia Following the COVID-19 Pandemic: a Longitudinal Observational Study
Butscheid, Y., Frey, P. M., Pfister, M., Pagani, L., Kouyos, R. D., Scheier, T. C., Staiger, W. I., Mancini, S., Brugger, S. D.
10.1101/2025.01.11.25320374 — Posted: 2025-01-15
Lower Cancer Incidence Three Years After COVID-19 Infection in a Large Veteran Population
Bradley, J., Tang, F., Resendes, N., Tosi, D., Hammel, I.
10.1101/2025.01.14.25320527 — Posted: 2025-01-15
Maternal Serum Hemoglobin Levels Relative to Anemia Interventions in the COVID-19 era: A systematic review and meta-analysis
MUTHUKA, J. K., Linus, A. M., K, L. N., Chebungei, L. C., Fondo, D. M., Kaweesi, R. N.
10.1101/2025.01.15.25320586 — Posted: 2025-01-15
SARS-CoV-2 nsp1 mediates broad inhibition of translation in mammals
Gen, R., Addetia, A., Asarnow, D., Park, Y.-J., Quispe, J., Chan, M. C., Brown, J. T., Lee, J., Campbell, M. G., Lapointe, C. P., Veesler, D.
10.1101/2025.01.14.633005 — Posted: 2025-01-15
Deciphering the Host-Pathogen Interface in COVID-19: The precision molecular insight into epitranscriptomic modifications of high-impact transcripts
Mazdziarz, M. A., Krawczyk, K., Lepiarczyk, E., Paukszto, L., Makowczenko, K. G., Moczulska, B., Iwanowicz, P., Kocbach, P., Sawicki, J., Gromadzinski, L., Majewska, M.
10.1101/2025.01.14.632961 — Posted: 2025-01-15
Unlocking the Secrets of NSP3: AlphaFold2-assisted Domain Determination in SARS-CoV-2 Protein
Edich, M., Briggs, D., Gao, Y., Thorn, A.
10.1101/2025.01.14.632924 — Posted: 2025-01-15
Trypstatin as a Novel TMPRSS2 Inhibitor with Broad-Spectrum 1 Efficacy Against Corona and Influenza Viruses
Lawrenz, J., Wettstein, L., Rodriguez Alfonso, A., Nchioua, R., von Maltitz, P., Albers, D., Zech, F., Vandeput, J., Stevaert, A., Fois, G., Preising, N., Schmierer, E., Almeida-Hernandez, Y., Petersen, M., Staendker, L., Wiese, S., Braubach, P., Frick, M., Sanchez-Garcia, E., Sauter, D., Kirchhoff, F., Naesens, L., Muench, J.
10.1101/2025.01.14.632953 — Posted: 2025-01-15
Metabolic syndrome enhances SARS-CoV-2 disease severity and reduces mRNA vaccine efficacy in a mouse model
Geeling, E., Stone, E. T., Carpenter, D., Dickson, A., Brien, J., Pinto, A. K.
10.1101/2025.01.15.633120 — Posted: 2025-01-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).